CytomX Therapeutics to Present at Upcoming September Investor Conferences

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will participate in the following investor conferences in September. Cantor Global Healthcare Conference 2025Date: Thursday, September 4, 2025Fireside Chat: 8:35 a.m. ETLocation: New York, NY H.C. Wainwright 27th Annual Global Investment ConferenceDate: Tuesday, September 9, 2025Formal Presentation: 11:30 ...